2
Participants
Start Date
February 25, 2021
Primary Completion Date
March 17, 2022
Study Completion Date
March 17, 2022
[11C]-PBR28
"A dose of ≤ 20 mCi (approximate range for most studies is anticipated to be 5-20 mCi) of \[11C\]-PBR28 will be administered by IV injection to the patient under the direct supervision of a Nuclear Medicine Authorized User. A lesser activity may be injected if, in the opinion of a nuclear medicine authorized user complete imaging data could be generated.~Subjects will undergo an approximately 90 minute dynamic PET/CT scan over the brain starting at approximately the same time as the \[11C\]-PBR-28 injection. Scans will be acquired using a Philips PET/CT time-of-flight Ingenuity scanner (Philips Healthcare, Cleveland, OH, USA). At the end of the dynamic imaging the participant will be allowed to get off the scanner."
University of Pennsylvania, Philadelphia
Collaborators (1)
Biogen
INDUSTRY
University of Miami
OTHER
University of Kansas
OTHER
University of Pennsylvania
OTHER